Eubiotics Market Synopsis

Eubiotics Market Size Was Valued at USD 5.46 Billion in 2023 and is Projected to Reach USD 11.76 Billion by 2032, Growing at a CAGR of 8.9% From 2024-2032.

Eubiotics are feed additives that enhance gut health and performance in livestock. They include probiotics, prebiotics, organic acids, and essential oils. Probiotics introduce beneficial bacteria, prebiotics provide food, and organic acids and essential oils control harmful pathogens. Eubiotics improve nutrient absorption, immunity, and digestive disorders, leading to improved growth rates and feed efficiency. They also serve as alternatives to traditional antibiotics.

• Eubiotics, including organic acids, probiotics, prebiotics, and essential oils, provide several benefits for a variety of businesses. These supplements improve immunological response, food absorption, and general health by supporting gastrointestinal health in pets, cattle, and aquaculture. Addressing worries about antimicrobial resistance and residues in food items, they lessen the demand for antibiotics. Eubiotics also increase growth rates and feed conversion efficiency, which maximizes output results in animal husbandry.
• The surge in demand for eubiotics can be attributed to several factors. Consumers are increasingly inclined towards natural alternatives over conventional additives, reflecting a broader movement towards clean-label and sustainable practices. Stringent regulations restricting antibiotic usage in animal feed have accelerated the adoption of eubiotics as safer and more environmentally friendly substitutes. Furthermore, the growing recognition of the gut microbiome's significance in maintaining health has sparked interest in eubiotics across various sectors, including human nutrition and pharmaceuticals.
• Global population expanding and dietary preferences shifting towards protein-rich diets, the demand for eubiotics is poised to increase. Emerging economies experiencing rapid urbanization and industrialization present significant markets for eubiotics, driven by the expansion of livestock production and heightened consumer awareness. In summary, the multifaceted advantages of eubiotics, combined with evolving consumer preferences and regulatory pressures, are driving their demand across diverse industries worldwide.

Eubiotics Market Trend Analysis

Increasing Awareness About Feed Quality and Safety

• The rising consciousness regarding the quality and safety of animal feed stands as a pivotal driver for the eubiotics market. With escalating concerns about food safety and the ecological impact of livestock farming on human health, consumers, regulatory bodies, and industry players are increasingly prioritizing measures to ensure the safety and standard of animal feed.
• Eubiotics emerge as a crucial solution in this context, offering natural and sustainable substitutes to conventional feed additives like antibiotics and synthetic growth enhancers. By fostering gut health and enhancing nutrient absorption in livestock, eubiotics contribute significantly to the production of safer and superior-quality animal products.
• Consumers gain a deeper understanding of the interplay between animal feed, animal welfare, and food safety, and there arises a growing demand for transparency and accountability across the feed supply chain. This shift towards clean-label and eco-friendly products further propels the adoption of eubiotics, which are perceived as safer and more environmentally conscious alternatives.

Rising Demand for Safe and Sustainable Food

• The rising demand for safe and sustainable food provides a significant opportunity for the eubiotics market. Consumers are increasingly concerned about the safety and sustainability of their food choices, leading to a preference for products produced using environmentally friendly practices. Eubiotics, including probiotics, prebiotics, organic acids, and essential oils, offer a natural and safe alternative to conventional additives in animal nutrition.
• Consumers seek assurances regarding the origin and production methods of their food, there is a growing inclination towards products that promote animal health and welfare while maintaining safety and environmental sustainability. Eubiotics play a pivotal role in meeting these expectations by enhancing gut health, optimizing nutrient absorption, and reducing reliance on antibiotics in livestock farming.
• Adoption of eubiotics aligns with regulatory initiatives aimed at fostering sustainable agriculture and minimizing the environmental footprint of food production. Companies that can leverage this trend by providing innovative eubiotic solutions tailored to modern consumer preferences are poised to capitalize on the escalating demand for safe and sustainable food options.

Eubiotics Market Segment Analysis:

Eubiotics Market Segmented on the basis of type, application, and end-users.

By Type, Probiotics segment is expected to dominate the market during the forecast period

• The probiotics segment is anticipated to lead the eubiotics market due to several compelling factors. Firstly, there's a growing acknowledgment of the significance of gut health in both human and animal nutrition. Probiotics, comprising beneficial live microorganisms, are widely recognized for their capacity to restore and maintain a balanced gut microbiome, resulting in enhanced digestion, immune function, and overall health.
• Increasing consumer awareness of the potential health advantages associated with probiotics has spurred demand across various sectors, including functional foods, dietary supplements, and animal feed. With a rising focus on preventive healthcare and natural remedies, probiotics are increasingly sought after as a safe and effective means to support well-being.
• Stringent regulations limiting antibiotic usage in animal feed have reinforced the demand for probiotics as safer and more sustainable alternatives. As livestock producers strive to enhance animal performance and fulfill consumer preferences for antibiotic-free products, the adoption of probiotics continues to escalate.

By Livestock, Poultry segment is expected to dominate the market during the forecast period

• The livestock and poultry segment is poised to dominate the eubiotics market for several reasons. Firstly, with the global population steadily increasing, there's a growing demand for protein-rich foods like meat and eggs, driving the need for effective solutions to improve animal health and productivity in these sectors.
• Concerns regarding disease management, antibiotic resistance, and environmental sustainability have heightened the appeal of eubiotics. These natural additives offer a sustainable approach to enhancing gut health, and nutrient absorption, and reducing antibiotic dependency in livestock and poultry farming, making them increasingly attractive to both producers and consumers.
• Regulatory restrictions on antibiotic use in animal feed further bolster the demand for eubiotics as safer alternatives. Given their proven efficacy in improving animal performance and well-being, eubiotics are poised to play a pivotal role in shaping the future of livestock and poultry production, thus cementing their expected dominance in the eubiotics market.

Eubiotics Market Regional Insights:

Asia Pacific is Expected to Dominate the Market Over the Forecast period

• The Asia-Pacific region is poised to lead the eubiotics market for several reasons. Rapid urbanization and economic expansion in nations such as China, India, and Southeast Asian countries are reshaping dietary preferences and consumer behaviors. With a growing middle class and rising incomes, there's a heightened demand for protein-rich foods, particularly meat and dairy.
• The Asia-Pacific region boasts a significant share of the global livestock population, encompassing poultry, swine, and ruminants. As the appetite for animal protein grows, so does the adoption of eubiotics to bolster animal health, productivity, and growth.
• Regulatory initiatives to curb antibiotic usage in animal feed are gaining momentum across the region, creating conducive conditions for the uptake of eubiotics as safer alternatives. Furthermore, increasing awareness among farmers and livestock producers regarding the advantages of eubiotics further propels market expansion in the area.
• The Asia-Pacific region is experiencing significant growth in the eubiotics market due to ongoing research and development, collaborations between industry players, academic institutions, and government agencies, and diverse agricultural landscapes and farming practices. This has led to market players expanding their presence and operations in this dynamic region to capitalize on the immense growth potential of the eubiotics market.

Eubiotics Market Top Key Players:

• Novus International, Inc. (US)
• UAS Laboratories (US)
• Advanced BioNutrition Corp (US)
• Kemin Industries, Inc. (US)
• DuPont de Nemours, Inc. (US)
• Cargill, Incorporated (US)
• ADM Animal Nutrition (US)
• Alltech, Inc. (US)
• Lallemand, Inc. (Canada)
• BENEO (Germany)
• Evonik Industries AG (Germany)
• BASF SE (Germany)
• Berg & Schmidt GmbH & Co. KG (Germany)
• Associated British Foods plc (UK)
• Nutreco N.V. (Netherlands)
• Orffa International Holding B.V. (Netherlands)
• DSM (Netherlands)
• Bluestar Adisseo Co. (France)
• Adisseo France SAS (France)
• Lesaffre Group (France)
• Pancosma SA (Switzerland)
• Novozymes (Denmark)
• Chr. Hansen Holding A/S (Denmark)
• BEHN MEYER (Singapore)
• Calpis Co., Ltd. (Japan), and Other Major Players.

Key Industry Developments in the Eubiotics Market:

• In January 2023, Cargill and BASF announced an expansion of their partnership in feed enzyme distribution and development to encompass the United States. This move aims to create a joint innovation pipeline to support the needs of the region's animal protein producers. With the growing demand for animal protein, producers are facing challenges in meeting consumer needs, prompting the companies to join forces in addressing these demands through collaborative efforts.

1. INTRODUCTION
   1. RESEARCH OBJECTIVES
   2. RESEARCH METHODOLOGY
   3. RESEARCH PROCESS
   4. SCOPE AND COVERAGE
      1. Market Definition
      2. Key Questions Answered
   5. MARKET SEGMENTATION
2. EXECUTIVE SUMMARY
3. MARKET OVERVIEW
4. GROWTH OPPORTUNITIES BY SEGMENT
5. MARKET LANDSCAPE
   1. PORTER’S FIVE FORCES ANALYSIS
      1. Bargaining Power Of Supplier
      2. Threat Of New Entrants
      3. Threat Of Substitutes
      4. Competitive Rivalry
      5. Bargaining Power Among Buyers
   2. INDUSTRY VALUE CHAIN ANALYSIS
   3. MARKET DYNAMICS
      1. Drivers
      2. Restraints
      3. Opportunities
      4. Challenges
   4. MARKET TREND ANALYSIS
   5. REGULATORY LANDSCAPE
   6. PESTLE ANALYSIS
   7. PRICE TREND ANALYSIS
   8. PATENT ANALYSIS
   9. TECHNOLOGY EVALUATION
   10. MARKET IMPACT OF THE RUSSIA-UKRAINE WAR
       1. Geopolitical Market Disruptions
       2. Supply Chain Disruptions
       3. Instability in Emerging Markets
   11. ECOSYSTEM
6. EUBIOTICS MARKET BY TYPE (2017-2032)
   1. EUBIOTICS MARKET SNAPSHOT AND GROWTH ENGINE
   2. MARKET OVERVIEW
   3. PREBIOTICS
      1. Introduction And Market Overview
      2. Historic And Forecasted Market Size in Value (2017 – 2032F)
      3. Historic And Forecasted Market Size in Volume (2017 – 2032F)
      4. Key Market Trends, Growth Factors And Opportunities
      5. Geographic Segmentation Analysis
   4. PROBIOTICS
   5. ORGANIC ACIDS
   6. ESSENTIAL OILS
7. EUBIOTICS MARKET BY LIVESTOCK (2017-2032)
   1. EUBIOTICS MARKET SNAPSHOT AND GROWTH ENGINE
   2. MARKET OVERVIEW
   3. SWINE
      1. Introduction And Market Overview
      2. Historic And Forecasted Market Size in Value (2017 – 2032F)
      3. Historic And Forecasted Market Size in Volume (2017 – 2032F)
      4. Key Market Trends, Growth Factors And Opportunities
      5. Geographic Segmentation Analysis
   4. POULTRY
   5. RUMINANTS
   6. AQUATIC ANIMALS
8. EUBIOTICS MARKET BY FUNCTION (2017-2032)
   1. EUBIOTICS MARKET SNAPSHOT AND GROWTH ENGINE
   2. MARKET OVERVIEW
   3. NUTRITION & GUT HEALTH
      1. Introduction And Market Overview
      2. Historic And Forecasted Market Size in Value (2017 – 2032F)
      3. Historic And Forecasted Market Size in Volume (2017 – 2032F)
      4. Key Market Trends, Growth Factors And Opportunities
      5. Geographic Segmentation Analysis
   4. YIELD
   5. IMMUNITY
   6. PRODUCTIVITY
9. EUBIOTICS MARKET BY FORM (2017-2032)
   1. EUBIOTICS MARKET SNAPSHOT AND GROWTH ENGINE
   2. MARKET OVERVIEW
   3. LIQUID
      1. Introduction And Market Overview
      2. Historic And Forecasted Market Size in Value (2017 – 2032F)
      3. Historic And Forecasted Market Size in Volume (2017 – 2032F)
      4. Key Market Trends, Growth Factors And Opportunities
      5. Geographic Segmentation Analysis
   4. DRY
   5. SOLID
10. COMPANY PROFILES AND COMPETITIVE ANALYSIS
    1. COMPETITIVE LANDSCAPE
       1. Competitive Positioning
       2. Eubiotics Market Share By Manufacturer (2023)
       3. Industry BCG Matrix
       4. Heat Map Analysis
       5. Mergers & Acquisitions
    2. NOVUS INTERNATIONAL, INC. (US)
       1. Company Overview
       2. Key Executives
       3. Company Snapshot
       4. Role of the Company in the Market
       5. Sustainability and Social Responsibility
       6. Operating Business Segments
       7. Product Portfolio
       8. Business Performance (Production Volume, Sales Volume, Sales Margin, Production Capacity, Capacity Utilization Rate)
       9. Key Strategic Moves And Recent Developments
       10. SWOT Analysis
    3. UAS LABORATORIES (US)
    4. ADVANCED BIONUTRITION CORP (US)
    5. KEMIN INDUSTRIES, INC. (US)
    6. DUPONT DE NEMOURS, INC. (US)
    7. CARGILL, INCORPORATED (US)
    8. ADM ANIMAL NUTRITION (US)
    9. ALLTECH, INC. (US)
    10. LALLEMAND, INC. (CANADA)
    11. BENEO (GERMANY)
    12. EVONIK INDUSTRIES AG (GERMANY)
    13. BASF SE (GERMANY)
    14. BERG & SCHMIDT GMBH & CO. KG (GERMANY)
    15. ASSOCIATED BRITISH FOODS PLC (UK)
    16. NUTRECO N.V. (NETHERLANDS)
    17. ORFFA INTERNATIONAL HOLDING B.V. (NETHERLANDS)
    18. DSM (NETHERLANDS)
    19. BLUESTAR ADISSEO CO. (FRANCE)
    20. ADISSEO FRANCE SAS (FRANCE)
    21. LESAFFRE GROUP (FRANCE)
    22. PANCOSMA SA (SWITZERLAND)
    23. NOVOZYMES (DENMARK)
    24. CHR. HANSEN HOLDING A/S (DENMARK)
    25. BEHN MEYER (SINGAPORE)
    26. CALPIS CO., LTD. (JAPAN)
11. GLOBAL EUBIOTICS MARKET BY REGION
    1. OVERVIEW
    2. NORTH AMERICA
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Type
       4. Historic And Forecasted Market Size By Livestock
       5. Historic And Forecasted Market Size By Function
       6. Historic And Forecasted Market Size By Form
       7. sHistoric And Forecasted Market Size By Country
          1. USA
          2. Canada
          3. Mexico
    3. EASTERN EUROPE
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Segments
       4. Historic And Forecasted Market Size By Country
          1. Russia
          2. Bulgaria
          3. The Czech Republic
          4. Hungary
          5. Poland
          6. Romania
          7. Rest Of Eastern Europe
    4. WESTERN EUROPE
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Segments
       4. Historic And Forecasted Market Size By Country
          1. Germany
          2. United Kingdom
          3. France
          4. The Netherlands
          5. Italy
          6. Spain
          7. Rest Of Western Europe
    5. ASIA PACIFIC
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Segments
       4. Historic And Forecasted Market Size By Country
          1. China
          2. India
          3. Japan
          4. South Korea
          5. Malaysia
          6. Thailand
          7. Vietnam
          8. The Philippines
          9. Australia
          10. New-Zealand
          11. Rest Of APAC
    6. MIDDLE EAST & AFRICA
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Segments
       4. Historic And Forecasted Market Size By Country
          1. Turkey
          2. Bahrain
          3. Kuwait
          4. Saudi Arabia
          5. Qatar
          6. UAE
          7. Israel
          8. South Africa
    7. SOUTH AMERICA
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Segments
       4. Historic And Forecasted Market Size By Country
          1. Brazil
          2. Argentina
          3. Rest of South America
12. INVESTMENT ANALYSIS
13. ANALYST VIEWPOINT AND CONCLUSION
    1. Recommendations and Concluding Analysis

Potential Market Strategies

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. EUBIOTICS MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. EUBIOTICS MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. EUBIOTICS MARKET COMPETITIVE RIVALRY
TABLE 005. EUBIOTICS MARKET THREAT OF NEW ENTRANTS
TABLE 006. EUBIOTICS MARKET THREAT OF SUBSTITUTES
TABLE 007. EUBIOTICS MARKET BY PRODUCT TYPE
TABLE 008. PROBIOTICS MARKET OVERVIEW (2016-2028)
TABLE 009. PREBIOTICS MARKET OVERVIEW (2016-2028)
TABLE 010. EXOGENOUS ENZYMES MARKET OVERVIEW (2016-2028)
TABLE 011. ORGANIC ACIDS MARKET OVERVIEW (2016-2028)
TABLE 012. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 013. EUBIOTICS MARKET BY FORM
TABLE 014. DRY MARKET OVERVIEW (2016-2028)
TABLE 015. LIQUID MARKET OVERVIEW (2016-2028)
TABLE 016. EUBIOTICS MARKET BY FUNCTION
TABLE 017. NUTRITION & GUT HEALTH MARKET OVERVIEW (2016-2028)
TABLE 018. PRODUCTION MARKET OVERVIEW (2016-2028)
TABLE 019. YIELD MARKET OVERVIEW (2016-2028)
TABLE 020. IMMUNITY MARKET OVERVIEW (2016-2028)
TABLE 021. EUBIOTICS MARKET BY LIVESTOCK
TABLE 022. RUMINANT MARKET OVERVIEW (2016-2028)
TABLE 023. SWINE MARKET OVERVIEW (2016-2028)
TABLE 024. POULTRY MARKET OVERVIEW (2016-2028)
TABLE 025. AQUACULTURE MARKET OVERVIEW (2016-2028)
TABLE 026. NORTH AMERICA EUBIOTICS MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 027. NORTH AMERICA EUBIOTICS MARKET, BY FORM (2016-2028)
TABLE 028. NORTH AMERICA EUBIOTICS MARKET, BY FUNCTION (2016-2028)
TABLE 029. NORTH AMERICA EUBIOTICS MARKET, BY LIVESTOCK (2016-2028)
TABLE 030. N EUBIOTICS MARKET, BY COUNTRY (2016-2028)
TABLE 031. EUROPE EUBIOTICS MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 032. EUROPE EUBIOTICS MARKET, BY FORM (2016-2028)
TABLE 033. EUROPE EUBIOTICS MARKET, BY FUNCTION (2016-2028)
TABLE 034. EUROPE EUBIOTICS MARKET, BY LIVESTOCK (2016-2028)
TABLE 035. EUBIOTICS MARKET, BY COUNTRY (2016-2028)
TABLE 036. ASIA PACIFIC EUBIOTICS MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 037. ASIA PACIFIC EUBIOTICS MARKET, BY FORM (2016-2028)
TABLE 038. ASIA PACIFIC EUBIOTICS MARKET, BY FUNCTION (2016-2028)
TABLE 039. ASIA PACIFIC EUBIOTICS MARKET, BY LIVESTOCK (2016-2028)
TABLE 040. EUBIOTICS MARKET, BY COUNTRY (2016-2028)
TABLE 041. MIDDLE EAST & AFRICA EUBIOTICS MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 042. MIDDLE EAST & AFRICA EUBIOTICS MARKET, BY FORM (2016-2028)
TABLE 043. MIDDLE EAST & AFRICA EUBIOTICS MARKET, BY FUNCTION (2016-2028)
TABLE 044. MIDDLE EAST & AFRICA EUBIOTICS MARKET, BY LIVESTOCK (2016-2028)
TABLE 045. EUBIOTICS MARKET, BY COUNTRY (2016-2028)
TABLE 046. SOUTH AMERICA EUBIOTICS MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 047. SOUTH AMERICA EUBIOTICS MARKET, BY FORM (2016-2028)
TABLE 048. SOUTH AMERICA EUBIOTICS MARKET, BY FUNCTION (2016-2028)
TABLE 049. SOUTH AMERICA EUBIOTICS MARKET, BY LIVESTOCK (2016-2028)
TABLE 050. EUBIOTICS MARKET, BY COUNTRY (2016-2028)
TABLE 051. BASF SE: SNAPSHOT
TABLE 052. BASF SE: BUSINESS PERFORMANCE
TABLE 053. BASF SE: PRODUCT PORTFOLIO
TABLE 054. BASF SE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 054. LALLEMAND INC.: SNAPSHOT
TABLE 055. LALLEMAND INC.: BUSINESS PERFORMANCE
TABLE 056. LALLEMAND INC.: PRODUCT PORTFOLIO
TABLE 057. LALLEMAND INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 057. CARGILL INCORPORATED: SNAPSHOT
TABLE 058. CARGILL INCORPORATED: BUSINESS PERFORMANCE
TABLE 059. CARGILL INCORPORATED: PRODUCT PORTFOLIO
TABLE 060. CARGILL INCORPORATED: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 060. CALPIS CO. LTD: SNAPSHOT
TABLE 061. CALPIS CO. LTD: BUSINESS PERFORMANCE
TABLE 062. CALPIS CO. LTD: PRODUCT PORTFOLIO
TABLE 063. CALPIS CO. LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 063. CHR. HANSEN A/S.: SNAPSHOT
TABLE 064. CHR. HANSEN A/S.: BUSINESS PERFORMANCE
TABLE 065. CHR. HANSEN A/S.: PRODUCT PORTFOLIO
TABLE 066. CHR. HANSEN A/S.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 066. KEMIN INDUSTRIES INC.: SNAPSHOT
TABLE 067. KEMIN INDUSTRIES INC.: BUSINESS PERFORMANCE
TABLE 068. KEMIN INDUSTRIES INC.: PRODUCT PORTFOLIO
TABLE 069. KEMIN INDUSTRIES INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 069. LESAFFRE GROUP: SNAPSHOT
TABLE 070. LESAFFRE GROUP: BUSINESS PERFORMANCE
TABLE 071. LESAFFRE GROUP: PRODUCT PORTFOLIO
TABLE 072. LESAFFRE GROUP: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 072. ADVANCED BIONUTRITION CORPORATION: SNAPSHOT
TABLE 073. ADVANCED BIONUTRITION CORPORATION: BUSINESS PERFORMANCE
TABLE 074. ADVANCED BIONUTRITION CORPORATION: PRODUCT PORTFOLIO
TABLE 075. ADVANCED BIONUTRITION CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 075. BEHN MEYER: SNAPSHOT
TABLE 076. BEHN MEYER: BUSINESS PERFORMANCE
TABLE 077. BEHN MEYER: PRODUCT PORTFOLIO
TABLE 078. BEHN MEYER: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 078. KONINKLIJKE DSM N.V.: SNAPSHOT
TABLE 079. KONINKLIJKE DSM N.V.: BUSINESS PERFORMANCE
TABLE 080. KONINKLIJKE DSM N.V.: PRODUCT PORTFOLIO
TABLE 081. KONINKLIJKE DSM N.V.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 081. NOVOZYMES.: SNAPSHOT
TABLE 082. NOVOZYMES.: BUSINESS PERFORMANCE
TABLE 083. NOVOZYMES.: PRODUCT PORTFOLIO
TABLE 084. NOVOZYMES.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 084. FRIESLAND CAMPINA: SNAPSHOT
TABLE 085. FRIESLAND CAMPINA: BUSINESS PERFORMANCE
TABLE 086. FRIESLAND CAMPINA: PRODUCT PORTFOLIO
TABLE 087. FRIESLAND CAMPINA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 087. ALLTECH: SNAPSHOT
TABLE 088. ALLTECH: BUSINESS PERFORMANCE
TABLE 089. ALLTECH: PRODUCT PORTFOLIO
TABLE 090. ALLTECH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 090. NOVUS INTERNATIONAL: SNAPSHOT
TABLE 091. NOVUS INTERNATIONAL: BUSINESS PERFORMANCE
TABLE 092. NOVUS INTERNATIONAL: PRODUCT PORTFOLIO
TABLE 093. NOVUS INTERNATIONAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 093. E.I.DU PONT DE NEMOURS AND COMPANY: SNAPSHOT
TABLE 094. E.I.DU PONT DE NEMOURS AND COMPANY: BUSINESS PERFORMANCE
TABLE 095. E.I.DU PONT DE NEMOURS AND COMPANY: PRODUCT PORTFOLIO
TABLE 096. E.I.DU PONT DE NEMOURS AND COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 096. OTHER MAJOR PLAYERS: SNAPSHOT
TABLE 097. OTHER MAJOR PLAYERS: BUSINESS PERFORMANCE
TABLE 098. OTHER MAJOR PLAYERS: PRODUCT PORTFOLIO
TABLE 099. OTHER MAJOR PLAYERS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. EUBIOTICS MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. EUBIOTICS MARKET OVERVIEW BY PRODUCT TYPE
FIGURE 012. PROBIOTICS MARKET OVERVIEW (2016-2028)
FIGURE 013. PREBIOTICS MARKET OVERVIEW (2016-2028)
FIGURE 014. EXOGENOUS ENZYMES MARKET OVERVIEW (2016-2028)
FIGURE 015. ORGANIC ACIDS MARKET OVERVIEW (2016-2028)
FIGURE 016. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 017. EUBIOTICS MARKET OVERVIEW BY FORM
FIGURE 018. DRY MARKET OVERVIEW (2016-2028)
FIGURE 019. LIQUID MARKET OVERVIEW (2016-2028)
FIGURE 020. EUBIOTICS MARKET OVERVIEW BY FUNCTION
FIGURE 021. NUTRITION & GUT HEALTH MARKET OVERVIEW (2016-2028)
FIGURE 022. PRODUCTION MARKET OVERVIEW (2016-2028)
FIGURE 023. YIELD MARKET OVERVIEW (2016-2028)
FIGURE 024. IMMUNITY MARKET OVERVIEW (2016-2028)
FIGURE 025. EUBIOTICS MARKET OVERVIEW BY LIVESTOCK
FIGURE 026. RUMINANT MARKET OVERVIEW (2016-2028)
FIGURE 027. SWINE MARKET OVERVIEW (2016-2028)
FIGURE 028. POULTRY MARKET OVERVIEW (2016-2028)
FIGURE 029. AQUACULTURE MARKET OVERVIEW (2016-2028)
FIGURE 030. NORTH AMERICA EUBIOTICS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 031. EUROPE EUBIOTICS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 032. ASIA PACIFIC EUBIOTICS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 033. MIDDLE EAST & AFRICA EUBIOTICS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 034. SOUTH AMERICA EUBIOTICS MARKET OVERVIEW BY COUNTRY (2016-2028)